Chemical and preclinical studies on Hedyotis diffusa with anticancer potential

Area of Science:

• Phytochemistry
• Pharmacology
• Traditional Chinese Medicine

Background:

• Hedyotis diffusa Willd. is a widely used herb in traditional Chinese medicine for cancer treatment.
• It is frequently incorporated into polyherbal formulas for its therapeutic properties.

Purpose of the Study:

• To comprehensively review the chemical constituents and preclinical anticancer research of Hedyotis diffusa.
• To summarize the anticancer activities, mechanisms of action, and potential therapeutic applications of H. diffusa.

Main Methods:

• Literature review of chemical and preclinical studies on Hedyotis diffusa.
• Identification and isolation of compounds from H. diffusa.
• Evaluation of anticancer effects of extracts and isolated compounds in preclinical cancer models.

Main Results:

• Sixty-nine compounds have been identified from H. diffusa, primarily anthraquinones, flavonoids, and terpenoids.
• Methanolic, ethanolic, and aqueous extracts of H. diffusa exhibited significant anticancer effects in various preclinical models.
• Specific constituents of H. diffusa demonstrated notable anticancer activity through various mechanisms.

Conclusions:

• Hedyotis diffusa possesses considerable potential as a therapeutic agent for cancer treatment.
• Further chemical and pharmacological investigations are warranted to fully elucidate its anticancer properties and mechanisms.